Octagon Capital Advisors as of March 31, 2022
Portfolio Holdings for Octagon Capital Advisors
Octagon Capital Advisors holds 24 positions in its portfolio as reported in the March 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Apellis Pharmaceuticals (APLS) | 25.7 | $119M | 2.3M | 50.81 | |
| Arcus Biosciences Incorporated (RCUS) | 17.0 | $79M | 2.5M | 31.56 | |
| Celldex Therapeutics Com New (CLDX) | 5.6 | $26M | 761k | 34.06 | |
| 4d Molecular Therapeutics In (FDMT) | 5.1 | $24M | 1.6M | 15.12 | |
| Bridgebio Pharma (BBIO) | 5.0 | $23M | 2.3M | 10.15 | |
| Gossamer Bio (GOSS) | 4.8 | $22M | 2.6M | 8.68 | |
| Chinook Therapeutics | 4.8 | $22M | 1.4M | 16.36 | |
| Keros Therapeutics (KROS) | 4.0 | $19M | 340k | 54.38 | |
| Stoke Therapeutics (STOK) | 3.7 | $17M | 814k | 21.05 | |
| I Mab Sponsored Ads (IMAB) | 3.7 | $17M | 1.0M | 16.24 | |
| Iteos Therapeutics (ITOS) | 3.1 | $15M | 451k | 32.18 | |
| Vera Therapeutics Cl A (VERA) | 2.9 | $14M | 575k | 23.49 | |
| Arvinas Ord (ARVN) | 2.6 | $12M | 179k | 67.30 | |
| Horizon Therapeutics Pub L SHS | 2.3 | $11M | 100k | 105.21 | |
| Century Therapeutics (IPSC) | 1.8 | $8.3M | 658k | 12.59 | |
| Immunovant (IMVT) | 1.8 | $8.1M | 1.5M | 5.51 | |
| Surface Oncology | 1.5 | $6.8M | 2.3M | 2.94 | |
| Avidity Biosciences Ord (RNA) | 1.3 | $5.9M | 322k | 18.47 | |
| Dyne Therapeutics (DYN) | 1.1 | $5.1M | 525k | 9.64 | |
| Spdr Ser Tr S&p Biotech (XBI) | 1.1 | $5.0M | 56k | 89.87 | |
| Prometheus Biosciences | 0.7 | $3.0M | 80k | 37.76 | |
| Omega Therapeutics Common Stock (OMGA) | 0.2 | $1.1M | 177k | 6.24 | |
| Connect Biopharma Hldgs Ads (CNTB) | 0.2 | $845k | 280k | 3.02 | |
| Ambrx Biopharma Sponsored Ads | 0.1 | $616k | 149k | 4.12 |
